MCT9 is also expressed in human umbilical vein endothelial cells where it may have a role in the pro-inflammatory response linked to carnitine (Figure 1)
[11] [4] mhra.gov.uk), which helps monitor medication safety
Each recommendation prioritizes tolerance and formulation quality over raw concentration, consistent with the evidence discussed above
Am J Med 105:54S-58S Tomassini V, Pozzilli C, Onesti E, Pasqualetti P, Marinelli F, Pisani A, Fieschi C (2004) Comparison of the effects of acetyl l-carnitine and amantadine for the treatment of fatigue in multiple sclerosis: results of a pilot, randomised, double-blind, crossover trial
Risk of Bone Fractures Associated With Glucagon-Like Peptide-1 Receptor Agonists Treatment: A Meta-Analysis of Randomized Controlled Trials
Hammarstedt, A., Gogg, S., Hedjazifar, S., Nerstedt, A